• Roche Holding (otc: RHHBY - news - people )is expected to release results of a big study showing that its experimental osteoporosis drug Boniva, which works by the same mechanism as Fosamax, can protect bones when given only once a month.

    FORBES: Breaking Merck's Bones

  • In the face of media scrutiny and a Congressional investigation, Merck and Schering disclosed results of the study in a press release in January.

    FORBES: Waiting For ENHANCE

  • The National Academy of Sciences will release a study that is expected to deem the Comprehensive Test Ban Treaty (CTBT) verifiable and further underground testing unnecessary.

    CENTERFORSECURITYPOLICY: Leading With No One Behind

  • Release of the editorial comes as a study published by BMJ Open - part of the British Medical Journal group - claimed that GPs were at high risk of burnout.

    BBC: Plans for NHS in England an unholy mess, say journals

  • Last August the dean of medicine issued a glowing press release about the program after its director published a very poor study arguing for the use of acupuncture.

    FORBES: The Forbes Post

  • The company didn't release full results of a 900-patient study testing Avastin against a placebo in combination with several chemotherapy regimens.

    FORBES: Genentech's Winning Streak

  • For the forthcoming initiative, the Chamber hopes to expand membership in ATM and release a study quantifying the economic benefits of infrastructure improvements.

    FORBES: Magazine Article

  • But Wyeth was unable to release any details because the study, part of a large set of clinical trials called the Women's Health Initiative (WHI), has not yet been published.

    FORBES: Wyeth's Confusing Alzheimer's News

  • The study of a sustained release oral formulation of the synthetic form of prostacylin showed that patients treated for pulmonary arterial hypertension did not achieve a statistically significant improvement in how far they were able to walk within six minutes by week 16 of the trial.

    FORBES: Pharma News: United Therapeutics, Zogenix, Par Pharmaceuticals

  • "The independent panel recommended focusing the primary endpoint to the common carotid artery to expedite the reporting of the study findings, " the companies said in a press release Nov. 19.

    FORBES: Magazine Article

  • According to a press release, the study failed to meet its pre-stated goal of helping patients do better on any of several questionnaires and tests designed to measure Alzheimer's severity.

    FORBES: Magazine Article

  • James Stein, a cardiologist at the University of Wisconsin, Madison, said before the release of the SEAS study that he believes any drug that lowers the bad cholesterol, or LDL, by 20% as Zetia does is likely to help patients, but that the benefit for Zetia is still unproven.

    FORBES: Another Blow For Merck And Schering

  • The company will release a 700-patient study in June that could offer doctors more information about the risks of leaving leads with insulation flaws in place.

    WSJ: Agonizing Choices for Heart Patients

  • But the new observational study (Abuse Rates and Routes of Administration of Reformulated Extended-Release Oxycodone: Initial Findings From a Sentinel Surveillance Sample of Individuals Assessed for Substance Abuse Treatment), suggests a breakthrough.

    FORBES: Is The Era Of OxyContin Abuse Over?

  • Although full results are not known, Celgene announced in its second-quarter earnings release Thursday that the study had been stopped ahead of schedule because the difference between patients getting Revlimid and those on a control group was already apparent.

    FORBES: Inside Medicine

  • That night, Merck and Schering-Plough issued a press release saying that an anonymous expert panel had advised them to take the extremely irregular step of changing the study's main goal, as set forth before the trial began.

    FORBES: Magazine Article

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定